dc.creator | Miranda, Hugo F. | |
dc.creator | Sierralta, Fernando | |
dc.creator | Pinardi, Gianni | |
dc.date.accessioned | 2019-01-29T17:51:52Z | |
dc.date.available | 2019-01-29T17:51:52Z | |
dc.date.created | 2019-01-29T17:51:52Z | |
dc.date.issued | 2002 | |
dc.identifier | British Journal of Pharmacology, Volumen 135, Issue 7, 2018, Pages 1591-1597 | |
dc.identifier | 00071188 | |
dc.identifier | 10.1038/sj.bjp.0704599 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/163590 | |
dc.description.abstract | 1. The common mechanism of action of non-steroidal anti-inflammatory drugs (NSAIDs) is the inhibition of the enzyme cyclo-oxygenase (COX), however, this inhibition is not enough to completely account for the efficacy of these agents in several models of acute pain. 2. It has been demonstrated that cholinergic agents can induce antinociception, but the nature of the interaction between these agents and NSAIDs drugs has not been studied. The present work evaluates, by isobolographic analysis, the interactions between the cholinergic indirect agonist neostigmine (NEO) and NSAIDs drugs, using a chemical algesiometric test. 3. Intraperitoneal (i.p.) or intrathecal (i.t.) administration of NEO and of the different NSAIDs produced dose-dependent antinociception in the acetic acid writhing test of the mouse. 4. The i.p. or i.t. co-administration of fixed ratios of ED 50 fractions of NSAIDs and NEO, resulted to be synergistic or supra-additive for the combinations ketoprofen (KETO) and NEO, par | |
dc.language | en | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | British Journal of Pharmacology | |
dc.subject | Antinociception | |
dc.subject | Isobolographic analysis | |
dc.subject | Neostigmine | |
dc.subject | NSAIDs | |
dc.subject | Writhing test | |
dc.title | Neostigmine interactions with non steroidal anti-inflammatory drugs | |
dc.type | Artículos de revistas | |